Revelstoke Capital Partners has made a significant growth investment in ClareMedica Health Partners, a leader in value-based primary care for Medicare Advantage members in Florida, to expand its innovative healthcare services into new markets.
Information on the Target
ClareMedica Health Partners, LLC, based in Florida, specializes in providing value-based primary care specifically tailored for Medicare Advantage members. The company has established itself as a leader in this sector, focusing on high-quality, coordinated healthcare that aims to improve health outcomes for its patients. Under the leadership of CEO Roberto Palenzuela, ClareMedica is poised to expand its innovative BetterCare℠ model into new markets, further enhancing its service offerings and reach.
ClareMedica operates through a network of employed and affiliated physicians, delivering comprehensive healthcare services with a patient-centric approach. This unique positioning not only benefits patients but also aligns closely with the evolving dynamics of the healthcare industry, which increasingly supports value-based care models.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Florida
The healthcare sector in Florida is undergoing a significant transformation driven by the adoption of value-based care models. As healthcare payers and providers shift away from traditional fee-for-service paradigm
Similar Deals
New Mountain Capital → Smarter Technologies
2025
Unifeye Vision Partners → Brooks Eye Associates
2025
Advantage Capital → Gravity Diagnostics
2025
Eir Partners → Porter
2025
Ampersand Capital Partners → Lexington Medical
2025
Ampersand Capital Partners → Gannet BioChem
2025
Revelstoke Capital Partners
invested in
ClareMedica Health Partners, LLC
in 2022
in a Growth Equity & Expansion Capital deal